- Home
- CRSR vs SANA Comparison
CRSR vs SANA Comparison
Compare CRSR & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- SANA
- Stock Information
- Founded
- CRSR 1994
- SANA 2018
- Country
- CRSR United States
- SANA United States
- Employees
- CRSR N/A
- SANA N/A
- Industry
- CRSR Computer Manufacturing
- SANA Medicinal Chemicals and Botanical Products
- Sector
- CRSR Technology
- SANA Health Care
- Exchange
- CRSR Nasdaq
- SANA Nasdaq
- Market Cap
- CRSR 698.8M
- SANA 522.4M
- IPO Year
- CRSR 2020
- SANA 2021
- Fundamental
- Price
- CRSR $7.64
- SANA $3.63
- Analyst Decision
- CRSR Buy
- SANA Strong Buy
- Analyst Count
- CRSR 6
- SANA 4
- Target Price
- CRSR $9.17
- SANA $13.00
- AVG Volume (30 Days)
- CRSR 538.7K
- SANA 13.2M
- Earning Date
- CRSR 02-11-2025
- SANA 02-27-2025
- Dividend Yield
- CRSR N/A
- SANA N/A
- EPS Growth
- CRSR N/A
- SANA N/A
- EPS
- CRSR N/A
- SANA N/A
- Revenue
- CRSR $1,320,042,000.00
- SANA N/A
- Revenue This Year
- CRSR N/A
- SANA N/A
- Revenue Next Year
- CRSR $13.04
- SANA N/A
- P/E Ratio
- CRSR N/A
- SANA N/A
- Revenue Growth
- CRSR N/A
- SANA N/A
- 52 Week Low
- CRSR $5.60
- SANA $1.52
- 52 Week High
- CRSR $14.13
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- CRSR 60.20
- SANA 65.77
- Support Level
- CRSR $7.19
- SANA $3.19
- Resistance Level
- CRSR $7.61
- SANA $7.30
- Average True Range (ATR)
- CRSR 0.32
- SANA 0.55
- MACD
- CRSR 0.10
- SANA 0.28
- Stochastic Oscillator
- CRSR 81.76
- SANA 36.51
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.